Issue of Equity

Assura Group Limited 17 October 2007 Assura Group Limited ('Assura' or the 'Company') Issue of equity The Company today announces that it has completed the acquisition of Cystoscope Hire Ltd and Urosonics Ltd. Both companies provide portable clinical equipment under contract to consultants and hospitals across London. These companies will be integral to Assura Diagnostics Limited, a new venture in which Assura has an 80 per cent financial interest. Consideration is in the form of 750,000 new ordinary shares of 10 pence each in the capital of Assura (the 'Consideration Shares'). Application has been made to the UK Listing Authority for admission of the Consideration Shares to the Official List and to the London Stock Exchange for admission to trading. It is expected that the admission will become effective and dealings in such shares will commence on or around 18 October 2007. The Consideration Shares will be subject to a lock up with respect to 50% until 31 March 2009 and 50% with respect to 31 March 2011. Assura Diagnostics will develop clinical equipment solutions for primary and secondary care customers and will work closely with Assura Medical to develop services that will support the government's aim of shifting care closer to the patient. Following admission of the Consideration Shares, the total number of 10 pence ordinary shares in the capital of the Company with voting rights will be 235,213,115. This information is provided by RNS The company news service from the London Stock Exchange

Companies

Assura (AGR)
UK 100